Literature DB >> 19369342

Kaposi's sarcoma-associated herpesvirus RTA promotes degradation of the Hey1 repressor protein through the ubiquitin proteasome pathway.

Faye Gould1, Sally M Harrison, Eric W Hewitt, Adrian Whitehouse.   

Abstract

The Kaposi's sarcoma-associated herpesvirus (KSHV) replication and transcription activator (RTA) protein regulates the latent-lytic switch by transactivating a variety of KSHV lytic and cellular promoters. RTA is a novel E3 ubiquitin ligase that targets a number of transcriptional repressor proteins for degradation by the ubiquitin proteasome pathway. Herein, we show that RTA interacts with the cellular transcriptional repressor protein Hey1. We demonstrate that Hey1 is a target for RTA-mediated ubiquitination and is subsequently degraded by the proteasome. Moreover, a Cys-plus-His-rich region within RTA is important for RTA-mediated degradation of Hey1. We confirm that Hey1 represses the RTA promoter and, furthermore, show that Hey1 binds to the RTA promoter. An interaction was observed between Hey1 and the corepressor mSin3A, and this interaction was abolished in the presence of RTA. Additionally, mSin3A associated with the RTA promoter in nonreactivated, but not reactivated, BCBL1 cells. Small interfering RNA knockdown of Hey1 in HEK 293T cells latently infected with the recombinant virus rKSHV.219 led to increased levels of RTA expression upon reactivation but was insufficient to induce complete lytic reactivation. These results suggest that other additional transcriptional repressors are also important in maintenance of KSHV latency. Taken together, our results suggest that Hey1 has a contributory role in the maintenance of KSHV latency and that disruption of the Hey1 repressosome by RTA-targeted degradation may be one step in the mechanism to regulate lytic reactivation.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19369342      PMCID: PMC2698570          DOI: 10.1128/JVI.00351-09

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  66 in total

1.  p53 inhibition by the LANA protein of KSHV protects against cell death.

Authors:  J Friborg; W Kong; M O Hottiger; G J Nabel
Journal:  Nature       Date:  1999 Dec 23-30       Impact factor: 49.962

2.  The activation domain of herpesvirus saimiri R protein interacts with the TATA-binding protein.

Authors:  K T Hall; A J Stevenson; D J Goodwin; P C Gibson; A F Markham; A Whitehouse
Journal:  J Virol       Date:  1999-12       Impact factor: 5.103

3.  Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.

Authors:  Sally M Harrison; Adrian Whitehouse
Journal:  FEBS Lett       Date:  2008-08-08       Impact factor: 4.124

4.  The herpesvirus saimiri ORF50 gene, encoding a transcriptional activator homologous to the Epstein-Barr virus R protein, is transcribed from two distinct promoters of different temporal phases.

Authors:  A Whitehouse; I M Carr; J C Griffiths; D M Meredith
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

Review 5.  Cytokine-mediated growth promotion of Kaposi's sarcoma and primary effusion lymphoma.

Authors:  B Ensoli; M Stürzl; P Monini
Journal:  Semin Cancer Biol       Date:  2000-10       Impact factor: 15.707

6.  Kaposi's sarcoma-associated herpesvirus open reading frame 50/Rta protein activates the entire viral lytic cycle in the HH-B2 primary effusion lymphoma cell line.

Authors:  L Gradoville; J Gerlach; E Grogan; D Shedd; S Nikiforow; C Metroka; G Miller
Journal:  J Virol       Date:  2000-07       Impact factor: 5.103

7.  Inhibition of NF-kappaB induces apoptosis of KSHV-infected primary effusion lymphoma cells.

Authors:  S A Keller; E J Schattner; E Cesarman
Journal:  Blood       Date:  2000-10-01       Impact factor: 22.113

8.  The latent nuclear antigen of Kaposi sarcoma-associated herpesvirus targets the retinoblastoma-E2F pathway and with the oncogene Hras transforms primary rat cells.

Authors:  S A Radkov; P Kellam; C Boshoff
Journal:  Nat Med       Date:  2000-10       Impact factor: 53.440

9.  X box binding protein XBP-1s transactivates the Kaposi's sarcoma-associated herpesvirus (KSHV) ORF50 promoter, linking plasma cell differentiation to KSHV reactivation from latency.

Authors:  Sam J Wilson; Edward H Tsao; Benjamin L J Webb; Hongtao Ye; Lucy Dalton-Griffin; Christoforos Tsantoulas; Catherine V Gale; Ming-Qing Du; Adrian Whitehouse; Paul Kellam
Journal:  J Virol       Date:  2007-10-10       Impact factor: 5.103

Review 10.  KSHV infection and the pathogenesis of Kaposi's sarcoma.

Authors:  Don Ganem
Journal:  Annu Rev Pathol       Date:  2006       Impact factor: 23.472

View more
  46 in total

1.  E3Net: a system for exploring E3-mediated regulatory networks of cellular functions.

Authors:  Youngwoong Han; Hodong Lee; Jong C Park; Gwan-Su Yi
Journal:  Mol Cell Proteomics       Date:  2011-12-22       Impact factor: 5.911

2.  Gammaherpesvirus 68 infection of endothelial cells requires both host autophagy genes and viral oncogenes for optimal survival and persistence.

Authors:  Andrea Luísa Suárez; Raymond Kong; Tad George; Liqiang He; Zhenyu Yue; Linda Faye van Dyk
Journal:  J Virol       Date:  2011-04-13       Impact factor: 5.103

3.  Role of RNF4 in the ubiquitination of Rta of Epstein-Barr virus.

Authors:  Ya-Chun Yang; Yushi Yoshikai; Shih-Wei Hsu; Hisato Saitoh; Li-Kwan Chang
Journal:  J Biol Chem       Date:  2013-03-15       Impact factor: 5.157

4.  Enhancement of autophagy during lytic replication by the Kaposi's sarcoma-associated herpesvirus replication and transcription activator.

Authors:  Hui-Ju Wen; Zhilong Yang; You Zhou; Charles Wood
Journal:  J Virol       Date:  2010-05-19       Impact factor: 5.103

5.  Downregulation of IRF4 induces lytic reactivation of KSHV in primary effusion lymphoma cells.

Authors:  Adriana Forero; Kevin D McCormick; Frank J Jenkins; Saumendra N Sarkar
Journal:  Virology       Date:  2014-05-05       Impact factor: 3.616

6.  Kaposi's Sarcoma-Associated Herpesvirus Reduces Cellular Myeloid Differentiation Primary-Response Gene 88 (MyD88) Expression via Modulation of Its RNA.

Authors:  Amy Lingel; Erica Ehlers; Qianli Wang; Mingxia Cao; Charles Wood; Rongtuan Lin; Luwen Zhang
Journal:  J Virol       Date:  2015-10-14       Impact factor: 5.103

7.  Murine gammaherpesvirus 68 evades host cytokine production via replication transactivator-induced RelA degradation.

Authors:  Xiaonan Dong; Zhiheng He; Deniz Durakoglugil; Lisa Arneson; Yan Shen; Pinghui Feng
Journal:  J Virol       Date:  2011-11-30       Impact factor: 5.103

8.  Kaposi sarcoma-associated herpesvirus degrades cellular Toll-interleukin-1 receptor domain-containing adaptor-inducing beta-interferon (TRIF).

Authors:  Humera Ahmad; Rachel Gubbels; Erica Ehlers; Florencia Meyer; Thomas Waterbury; Rongtuan Lin; Luwen Zhang
Journal:  J Biol Chem       Date:  2011-01-06       Impact factor: 5.157

9.  Kaposi's sarcoma-associated herpesvirus ORF57 protein interacts with PYM to enhance translation of viral intronless mRNAs.

Authors:  James R Boyne; Brian R Jackson; Adam Taylor; Stuart A Macnab; Adrian Whitehouse
Journal:  EMBO J       Date:  2010-04-30       Impact factor: 11.598

Review 10.  Keeping it quiet: chromatin control of gammaherpesvirus latency.

Authors:  Paul M Lieberman
Journal:  Nat Rev Microbiol       Date:  2013-11-06       Impact factor: 60.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.